Skip to main content

ADVERTISEMENT

Iqbal S. Malik, MD, MRCP, PhD, FRCP

Original Contribution
09/15/2008
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT:...
09/15/2008
Journal of Invasive Cardiology
Clinical Images
07/01/2016
A 90-year-old patients underwent valve-in-valve transcatheter aortic valve implantation via the transfemoral route in view of the patient’s prohibitively high surgical and anesthetic risk.
A 90-year-old patients underwent valve-in-valve transcatheter aortic valve implantation via the transfemoral route in view of the patient’s prohibitively high surgical and anesthetic risk.
A 90-year-old patients underwent...
07/01/2016
Journal of Invasive Cardiology